Deaconess is administering antiviral therapies to help prevent hospitalization for COVID-19. Some of these medications are FDA approved, and others are under emergency use authorization (EUA).
This oral medication is available by prescription only. A prescription can be obtained by your primary care provider or a through a Deaconess Clinic Urgent Care Video Visit. The provider will need to carefully review your complete medication list to avoid potentially dangerous medication interactions. In some cases, lab tests may be needed prior to filling the prescription.
This FDA-approved medication is given as an infusion treatment of mild-to-moderate COVID-19 in patients who are at high risk of progressing to severe COVID-19 and/or hospitalization.
Do you have concerns about your out of pocket portion for your remdesivir (Veklury®) therapy? See the flyer below for how the Deaconess Medication Assistance Program can help you apply for assistance.
This oral medication is available by prescription only, and is only available through certain retail pharmacies (not Deaconess).
Criteria for these outpatient treatments:
Patients must have had symptoms for less than 5-7 days.
These treatments are NOT authorized for:
All moderately-to-severely immunocompromised patients regardless of vaccination status (adult and pediatric)
Patients age 65 and older
Unvaccinated patients age 55-64 with at least one risk factor below
Qualifying risk factors:
- BMI ≥ 35
- Chronic Kidney Disease
- Cardiovascular disease
- COPD/chronic respiratory disease
Unvaccinated pregnant patients
Vaccinated pregnant patients who are at least 24 weeks gestational age
Unvaccinated with Trisomy 21/Down syndrome or intellectual disability that requires group home status
Unvaccinated with cerebral palsy
Age < 18, unvaccinated with one of the following:
Trisomy 21/Down syndrome or intellectual disability that requires group home status
Type 1 Diabetes Mellitus
BMI in the 95th percentile for age
Sickle Cell disease (not trait)
Treatment should be started as early as possible.
- Patients who are already seriously ill due to COVID-19 (already hospitalized, on oxygen)
- Patients with COVID-19 symptom onset > 5-7 days
- Clinical trial data shows most benefit in patients with symptoms of 5-7 days or less, depending on which treatment is available.
If you believe you are a candidate for one of these treatments, contact your Primary Care provider or schedule an appointment now with a Deaconess Clinic Live
provider. Your Primary Care provider or Deaconess Clinic Live provider will assess your symptoms and/or risks, and will recommend any needed treatment.
Some of these treatments will have out-of-pocket costs
for the medication itself, or costs to administer the medication, or both. To learn what your costs may be based on your specific insurance, call 812-450-COST (2678).